Clinical Signs, Laboratory Diagnosis and Treatments Involved in Corona Viruses-19

Authors

  • Israa Burhan Raoof Department of Clinical Laboratory Science, College of Pharmacy, Mustansiriyah University, Iraq.
  • Zahraa Ahmed Okhti Department of Clinical Laboratory Science, College of Pharmacy, Mustansiriyah University, Iraq
  • Mayssaa E. Abdalah Department of Clinical Laboratory Science, College of Pharmacy, Mustansiriyah University, Iraq

DOI:

https://doi.org/10.32947/ajps.v21i1.776

Keywords:

coronavirus, Clinical Signs, Laboratory Diagnosis and Treatments

Abstract

Covid -19 is a viral disease play important role in danger pathogens for human, it is infecting on respiratory, hepatic, central nervous systems and gastrointestinal, in addition to that, the triggers included cytokine storm is inflammatory response to viral infection

 

 

Therefore, excessive enhance of immune cells lead to new of pro-inflammatory cytokines. COVID-19 interaction with the cardiovascular system on different levels, rising death percent in people underlying cardiovascular state provoking myocardial injury. Respiratory infection varying from   mild  cold to  the severe illness like  as Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome the most important coronavirus (COVID-19) complications, however individuals with asymptomatic disease were also suspected of possible infectious transmission, which further adds to the uncertainty of the dynamic of disease transmission in COVID-19 infections, Suppression of  angiotensin-converting enzyme (ACE2) expression by inflammatory cytokines accompanied by the decrease of estrogens and androgens  of the elderly, establish a negative correlation between   ACE2 expression and mortality in other cases may lead to infertility. Early detection by PCR has aided the identification of the pathogen at an early level.  Furthermore, the treatment includes the effectiveness of glucocorticoid drugs (dexamethasone), anti-malaria drug (hydroxychloroquine), azithromycin (antibacterial drug) and favipiravir are all drugs recommended in illness with Covid-19. Remdesivir suppression COVID-19 replication and decreases viral load, alleviates clinical signs and improves pulmonary injury, therefore Remdesivir drug has been used as a compassionate medicine for treating COVID-19 patients.

References

- Mahendra Pal, Gemechu Berhane, Chaltu Desalegn, Venkataramana Kandi. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Cureus. 2020; 12(3): 3-13.

- Chen Y. Liu Q. Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020; 92:418–23.

- Chan J. Yuan S. Kok K. To K. Chu H. Yang J. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto- person transmission: a study of a family cluster. Lancet. 2020; 395 :514-23.

- Wang C. Horby P. Hayden F. Gao G. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395:470-3.

- Fehr A. Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015; 1282:1-23.

- Weiss S. Leibowitz J. Coronavirus pathogenesis. Adv Virus Res. 2011; 81:85-164.

- Nie Q. Luo X. Hui W. Advances in clinical diagnosis and treatment of severe acute respiratory syndrome. World J Gastroenterol. 2003; 9:1139-1143.

- Pal M. Severe acute respiratory syndrome: a newly recognized viral zoonosis of public health concern. Acta Scientific Microbiology. 2018; 1:1.

- Huang C. Wang Y. Li X. et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497-506.

- Maggio M. Basaria S. Ceda G. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest. 2005; 28:116–119.

- Nettleship J. Pugh P. Channer K. Jones T. Jones R. Inverse relationship between serum levels of interleukin-1β and testosterone in men with stable coronary artery disease. Horm Metab Res. 2007; 39:366–371.

- Chen J. Jiang Q. Xia X. Liu K. Yu Z. Tao W. Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation.Aging cell. 2020; 19(7):1-20.

- Traish A. Bolanos J. Nair S. Saad F. Morgentaler A. Do androgens modulate the pathophysiological pathways of inflammation? Appraisingthe contemporary evidence. J Clin Med. 2018; 7(12):549.

- Tsilidis K. Rohrmann S. McGlynn K. et al. Association between endogenous sex steroid hormones and inflammatory biomarkers in US men. Andrology. 2013; 1(6):919-928.

- Baillargeon J. Al Snih S. Raji M. et al. Hypogonadism and the risk of rheumatic autoimmune disease. Clin Rheumatol. 2016; 35(12):2983-2987

- Stocco C. Tissue physiology and pathology of aromatase. Steroids. 2012; 77(1-2):27-35.

- Tikellis C. Thomas M. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012; 2012: 256294.

- Zhang H. Penninger J. Li Y. Zhong N. Slutsky A. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. 2020; 46:586–590.

- Wang D. Hu B. Hu C. et al.: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020, 323:1061-1069.

- Lu R. Zhao X. Li J. et al.: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395: 565-574.

- Kanne J. Chest C. findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. 2020; 295(1):16-1.

- Kim H. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? Euro Radio. 2020; 30(6):3266-3267.

- Ng M. Lee E. Yang J. et al. Imaging profile of the COVID-19 infection: Radiologic findings and literature review. Radiology: Cardiothoracic Imaging 2020;2(1): e200034.

- Song F. Shi N. Shan F. et al. Emerging coronavirus 2019- nCoV pneumonia. Radiology 2020: 295(1): 210-217.

- Bilian Y. Xin L. Jin C. et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.J Thromb Thrombolysis. 2020: 50(3): 548-557.

- Warren T. Jordan R. Lo M. et al. Therapeutic efficacy of the small molecule GS5734 against Ebola virus in rhesus monkeys. Nature. 2016; 531(7594):381–385

- Wu C. Chen X. Cai Y. Xia J. Zhou X. Xu S. et al. Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7): 934-943.

- Beutels P. Jia N. Zhou Q. Smith R. Cao W. de Vlas S. The economic impact of SARS in Beijing, China. Trop Med Int Health. 2009; 14:85-91.

- Abdul H. Shmmon A. Sameera A. Mumtaz A. 1 Shruti M. A Review of COVID-19 (Coronavirus Disease-2019) Diagnosis, Treatments and Prevention. EJMO 2020; 4(2):116–125

Downloads

Published

2022-04-19